Xenon Pharmaceuticals Inc.

NasdaqGM:XENE Stock Report

Market Cap: US$3.0b

Xenon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:XENE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Mar 24BuyUS$12,155Robin SherringtonIndividual1,234US$9.85
07 Mar 24SellUS$231,513Steven GannonIndividual5,000US$46.30
07 Mar 24SellUS$601,615Steven GannonIndividual13,000US$46.45
07 Mar 24SellUS$446,789Steven GannonIndividual13,000US$34.50
14 Dec 23SellUS$311,898Gary PatouIndividual7,598US$41.05

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of XENE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies94,4540.125%
Individual Insiders105,0770.139%
General Public233,0910.308%
Hedge Funds5,666,6667.48%
Institutions69,665,21791.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.1%.


Top Shareholders

Top 25 shareholders own 72.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.93%
FMR LLC
6,768,173US$266.5m2.52%0.02%
7.48%
Avoro Capital Advisors LLC
5,666,666US$223.1m0%2.83%
6.81%
Capital Research and Management Company
5,157,396US$203.0m0%0.01%
5.83%
Driehaus Capital Management LLC
4,419,472US$174.0m2.26%1.18%
5.05%
Wellington Management Group LLP
3,828,221US$150.7m-2.39%0.02%
3.64%
Commodore Capital LP
2,754,266US$108.4m27.1%6.63%
3.38%
Braidwell LP
2,560,573US$100.8m95.8%4.62%
3.35%
Polar Capital Holdings Plc
2,536,058US$99.8m-2.91%0.39%
2.77%
BlackRock, Inc.
2,095,894US$82.5m-1.23%no data
2.7%
Paradigm Biocapital Advisors LP
2,043,280US$80.4m-17.8%2.85%
2.43%
Adage Capital Management, L.P.
1,839,555US$72.4m10%0.13%
1.96%
AllianceBernstein L.P.
1,483,166US$58.4m1%0.02%
1.95%
Pictet Asset Management Limited
1,479,491US$58.2m-2.37%0.04%
1.9%
T. Rowe Price Group, Inc.
1,439,903US$56.7m0.95%0.01%
1.83%
Marshall Wace LLP
1,384,674US$54.5m-4.53%0.09%
1.72%
First Light Asset Management, LLC
1,306,260US$51.4m-1.05%3.92%
1.68%
Rock Springs Capital Management LP
1,272,877US$50.1m1.38%1.45%
1.38%
Janus Henderson Group plc
1,045,257US$41.2m11%0.02%
1.31%
Affinity Asset Advisors, LLC
994,227US$39.1m18.7%6.31%
1.31%
Baker Bros. Advisors LP
993,679US$39.1m0%0.37%
1.14%
OrbiMed Advisors LLC
862,362US$34.0m56.8%0.47%
1.12%
Invesco Ltd.
847,999US$33.4m-5.17%0.01%
1.01%
Citadel Advisors LLC
768,726US$30.3m-40.3%0.03%
1%
TimesSquare Capital Management, LLC
754,493US$29.7m2.35%0.43%
1%
Avidity Partners Management, L.P.
754,000US$29.7m6.2%1.15%